{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6721e7bc8c8e0138f00e328e/67322e429395568d2789ca2e?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"BONESUPPORT Holding AB Q3 2024 Earnings Call","description":"<p>Join the hosts as they break down BONESUPPORT Holding AB's Q3 2024 interim report. This episode will cover the company’s impressive 54% sales growth (CER) fueled by the success of CERAMENT® G in the US, as well as their strong earnings performance. The discussion will also cover highlights from the quarter, including the topline results from the SOLARIO study, which demonstrated a potential paradigm shift in the treatment of bone infections.</p>","author_name":"Finna AB"}